IMV Inc IMVIQ

Let's forget about the meme action for a second

[abe492]

The results I think were  fantastic and gives hope for cancer paitents.  Ovarian cancer is extremely hard to treat.  First, there is a limited amount of drugs that can treat it, second the patient positive percetage respond to a certian treatement is not that high and lastly if the paitents do respond well to a treatment the remission is not long with potiential of nasty side effects.  44.9% at 23.8 months of follow up and a median overall survival of 19.9 months is great.  I can imagine certain Investors / funds would like 55%, 60% etc. in reality is not going to happen at this time of age, hopefully in 8-10 years as techonology advances we will see those numbers.   The $$$ money here is 1: well-tolerated, 2: extends LIFE for these human biengs, 3:  potiential modification of the drug with other treatments and dosage, this is just the tip of the iceburg